ANIXA BIOSCIENCES, INC. Operating Lease Liability
ANIXA BIOSCIENCES, INC. (ANIX) had Operating Lease Liability of $174.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-09-09
- 2026-07-31: Operating Lease, Liability $174.00K.
- 2026-04-30: Operating Lease, Liability $184.00K.
- 2026-01-31: Operating Lease, Liability $193.00K.
- 2025-10-31: Operating Lease, Liability $204.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-07-31 | $174.00K 10-Q · filed 2026-09-09 |
| 2026-04-30 | $184.00K 10-Q · filed 2026-06-10 |
| 2026-01-31 | $193.00K 10-Q · filed 2026-03-09 |
| 2025-10-31 | $204.00K 10-K · filed 2026-01-12 |
| 2025-07-31 | $213.00K 10-Q · filed 2025-09-10 |
| 2025-04-30 | $221.00K 10-Q · filed 2025-05-28 |
| 2025-01-31 | $230.00K 10-Q · filed 2025-03-11 |
| 2024-10-31 | $232.00K 10-K · filed 2025-01-10 |
| 2024-07-31 | $237.00K 10-Q · filed 2024-09-06 |
| 2024-04-30 | $149.00K 10-Q · filed 2024-06-04 |
| 2024-01-31 | $162.00K 10-Q · filed 2024-03-12 |
| 2023-10-31 | $175.00K 10-K · filed 2024-01-16 |
| 2023-07-31 | $187.00K 10-Q · filed 2023-09-06 |
| 2023-04-30 | $198.00K 10-Q · filed 2023-06-14 |
| 2023-01-31 | $209.00K 10-Q · filed 2023-03-17 |
| 2022-10-31 | $221.00K 10-K · filed 2023-01-04 |
| 2022-07-31 | $231.00K 10-Q · filed 2022-09-09 |
| 2022-04-30 | $241.00K 10-Q · filed 2022-06-10 |
| 2022-01-31 | $250.00 10-Q · filed 2022-03-11 |
| 2021-10-31 | $259.48K 10-K · filed 2022-01-04 |
| 2021-07-31 | $10.57K 10-Q · filed 2021-09-01 |
| 2021-04-30 | $25.96K 10-Q · filed 2021-06-10 |
| 2021-01-31 | $40.84K 10-Q · filed 2021-03-11 |
| 2020-10-31 | $55.20K 10-K · filed 2021-01-07 |
| 2020-07-31 | $68.76K 10-Q · filed 2020-09-08 |
| 2020-04-30 | $81.71K 10-Q · filed 2020-06-09 |
| 2020-01-31 | $94.22K 10-Q · filed 2020-03-09 |
| 2019-11-01 | $106.30K 10-Q · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |